Regulatory Open Forum

 View Only
  • 1.  USPR (PADER Submission)

    Posted 15-Mar-2017 02:41

    Hello,

     

    Could you please let me know how everyone is publishing the PADER Submission as an amendment or other.



  • 2.  RE: USPR (PADER Submission)

    Posted 16-Mar-2017 10:05
    Hi Shaista,

    We have been publishing our PADER submission as "Other" using docuBridge software.

    Regards,
    Myleene

    ------------------------------
    Myleene Consignado
    Project Leader Regulatory Affairs
    ApoPharma Inc.
    North York ON
    Canada
    ------------------------------



  • 3.  RE: USPR (PADER Submission)

    Posted 16-Mar-2017 19:26
    For PADER,

    Fill the 356h form for specific section as below:

    21. Submission - Periodic Safety Report
    22. Submission Sub-Type - Initial Submission
    25. Reason for Submission - PADER for mm/dd/yyyy to mm/dd/yyyy

    Below link is for your ready reference:

    eCTD Important Notices


    Once you click the above link, you will find below information:

    Submission of periodic safety reports to the eCTD

    Periodic safety reports consist of two parts: a descriptive portion and the individual case safety reports (ICSRs).  Only the descriptive portion of the periodic safety report can be submitted to the eCTD.
     
    Descriptive portion:
    Firms can submit the descriptive portion of the periodic safety report in the following formats: the periodic adverse drug experience report, the periodic adverse experience report or, with an approved waiver, either the periodic safety update report or the periodic benefit-risk evaluation report.  The descriptive portion can be submitted to the eCTD in module 5.3.6 and should indicate that the ICSRs have been submitted electronically as XML files to the FDA Electronic Submissions Gateway (ESG).
     
    ICSRs:
    Firms can submit ICSRs electronically using ICH E2B(R) standards via the FDA Electronic Submission Gateway (ESG) or via the Safety Reporting Portal (SRP). Submission of ICSRs to the eCTD is not acceptable because these ICSRs cannot be processed into the FDA Adverse Event Reporting System (FAERS) database.







    ------------------------------
    Gaurang Bhavsar
    Edison NJ
    United States
    ------------------------------



  • 4.  RE: USPR (PADER Submission)

    Posted 17-Mar-2017 18:56

    Thank you all!

     

    Shaista Hussain

     

    Global Submission Publisher

    Global Drug Development

    Regulatory Affairs